Perspective Therapeutics Profit Margin

Perspective Therapeutics (ISR) currently reports a profit margin of 153202.63% as of June 2026. That compares with 2281.28% in the prior-year period — up 6615.6% year over year. That is above the Industrials sector average of 10.14%. Use the charts on this page to explore Perspective Therapeutics's profit margin history and peer comparisons.

Perspective Therapeutics's profit margin increased from 2281.28% to 153202.63% — a 6615.6% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Perspective Therapeutics's profit margin of 153202.63% is higher than the Industrials sector average of 10.14%. That is roughly 1510463.3% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Perspective Therapeutics's current 153202.63% should be judged against Industrials norms (sector average: 10.14%) and against ISR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 153202.63%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Industrials average is 10.14%. From there, open related valuation or income-statement pages for Perspective Therapeutics, and consider following ISR for alerts when major investors trade the stock.